OOIR: Observatory of International Research

Papers

(The TQCC of Hematology-Oncology Clinics of North America is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver	140
Copyright	72
Forthcoming Issues	66
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis	40
Treatment of High-Risk Gestational Trophoblastic Neoplasia	36
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia	35
Autoimmune Hemolytic Anemia: An Old Disease with New Twists	35
Insights into Renal Cell Carcinoma with Novel Imaging Approaches	35
Conflict and Access to Health Care	34
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia	33
Managing First-Line Metastatic Renal Cell Carcinoma	33
Future Directions for Gestational Trophoblastic Disease	33
Benefits and Harms of Interception and Early Detection of Cancer	29
Advances in Gastric Cancer Surgical Management	27
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	25
Updates in the Management of Warm Autoimmune Hemolytic Anemia	25
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes	25
Hematology/Oncology Clinics of North America	24
Contributors	23
Contents	23
Disparities in Breast Cancer Outcomes and How to Resolve Them	22
Contributors	22
Copyright	21
Factor XIII Deficiency	19
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	18

Advances in Immunotherapy in Esophagogastric Cancer	18
Contents	17
Liposarcoma	16
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma	16
Advances in Surgical Techniques for Lung Cancer	15
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas	15
The Need for Translational Epidemiology in Beta Thalassemia Syndromes	15
Foreword	15
Histiocytic Disorders in Pediatric and Adult Patients	14
Clinical Characteristics and Treatment of Histiocytic Disorders in Children	14
Adult Evans' Syndrome	13
Copyright	13
Emerging Therapies in β-Thalassemia	13
Advances in Systemic Therapy in Pancreatic Cancer	13
Genomic Alterations in Langerhans Cell Histiocytosis	13
Inherited Platelet Disorders	13
Skin Cancer Precursors	13
Clinical Vignettes Part I	12
Red Cell Antigens and Antibodies	12
The Evolving Role of Surgery in Multimodal Cancer Care	12
Evaluation and Management of Bing–Neel Syndrome	12
Forthcoming Issues	12
Malignancies of the Upper Gastrointestinal Tract	11
Copyright	11
Hereditary Renal Cell Carcinoma Syndromes	11
The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors	11
Genes as Medicine	11
Gestational Trophoblastic Neoplasia	11
Local Control in Soft Tissue Sarcomas	10
High-Risk Non-Melanoma Skin Cancers	10
Patient-Reported Outcomes in Radiation Oncology	10
Advances in the Surgical Management of Esophageal Cancer	10
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy	9
Heavy Ion Particle Therapy in Modern Day Radiation Oncology	9
Contents	9
CAR T Cells: Past Successes, Current Limitations, and Future Opportunities	9
Evolution of Gene Therapy, Historical Perspective	9
New Developments in Myeloma	8
Melanoma Brain Metastasis	8
Radiation-Induced Tissue Regeneration	8
Forthcoming Issues	8
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms	8
Bispecific Antibodies in the Treatment of Multiple Myeloma	8
Contents	8
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer	8
Disparities and Inequities Among Patients with Central Nervous System Tumor	7
Education and Training Models for Remote Learning	7
Breast Cancer and Lifestyle Factors	7
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma	7
Clinical Complications and Their Management	7

Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers	7
Copyright	7
Breast Cancer in India	7
Copyright	7
Contents	7
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases	6
FLASH Radiotherapy	6
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?	6
Hemophilia A/B	6
Disorders of Fibrinogen and Fibrinolysis	6
Ductal Carcinoma In Situ	6
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies	6
Early Detection of Precursor Diseases of Multiple Myeloma	6
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma	6
Targeted Therapy Innovations for Melanoma	6
Impact of Clonal Heterogeneity in Multiple Myeloma	6
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors	6
Pathogenic Mechanisms in Thalassemia I	5
Pathogenic Mechanisms in Thalassemia II	5
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy	5
Renal Cell Cancer	5
Local Therapies in Advanced Colorectal Cancer	5
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors	5
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)	5
Immune-Pathogenesis of Myeloma	5
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma	5
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia	5
Copyright	5
Complications of Autoimmune Hemolytic Anemia	5
Merkel Cell Carcinoma	5
Remembering the Contributions of Professor David J. Weatherall	5
Contents	5
Sarcomas	5
Genetics and Genomics of Gestational Trophoblastic Disease	5
Contributors	5
Immunotherapy-associated Autoimmune Hemolytic Anemia	5
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia	5
Contributors	5
Forthcoming Issues	5
Approach to High-Risk Multiple Myeloma	5
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis	5
When Is It Important to Sequence Sarcomas and Other Mesenchymal Neoplasms? A Practical Guide to Molecular Testing	5